Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Abortion, Habitual

• Prednisolone Administration in Patients With Unexplained REcurrent MIscarriages
• Effects of Co-treatment on Endometrial abv3-integrin Expressions in Women With Recurrent Implantation Failure
• HOPE Trial hCG or Progesterone Effect on Recurrent Pregnancy Loss
• Uterine Artery Doppler Changes After Vaginal Administration of Isosorbide Mononitrate In Patients With URPL
• Hydroxychloroquine in Unexplained Recurrent Pregnancy Loss
• Effect of Sildenafil Citrate on Mid Luteal Phase Uterine Artery Blood Flow in Patients With Recurrent Pregnancy Loss
• The Use of High Concentration Hyaluronic Acid (HA) Transfer Medium in Repeated Implantation Failure (RIF) Patients
• Intravenous Immunoglobulin and Prednisolone for RPL After ART.
• A Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Spontaneous Abortion With Antiphospholipid Syndrome
• Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss
• Hydroxychloroquine and Unexplained Recurrent Miscarriage
• Low-dose Interleukin-2 in Women With Unexplained Miscarriages
• Effect of Prednisolone Treatment on Uterine Natural Killer Cells
• Sildenafil Citrate in Early Unexplained Recurrent Pregnancy Loss
• Immunosuppressant Regimens for Living Fetuses Study
• Sildenafil Citrate and Recurrent Abortion
• Assessing the Endometrial Environment in Recurrent Pregnancy Loss and Unexplained Infertility
• Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss
• Immunomodulatory Effects of IVIg on Pregnancy Rate of Patient With Recurrent Pregnancy Loss
• Hydroxychloroquine for Prevention of Recurrent Miscarriage.
• Intralipid Related Effect on NKcells in Patients With Unexplained Recurrent Spontaneous Abortion
• The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss
• RECAB-ASA; Treatment of Recurrent Abortion With Aspirin
• Use of Cyclosporin A for the Treatment of Recurrent Miscarriage
• Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss
• Timing of Initiation of LMWH Administration in Pregnant Women With APS
• Use of Warfarin After the First Trimester in Pregnant Women With APS
• A Study of the Efficacy and Safety of GB-0998 in Patients With Unexplained Recurrent Miscarriage
• A Multi-center, Placebo-controlled Study to Evaluate NT100 in Pregnant Women With a History of Unexplained Recurrent Pregnancy Loss (RPL)
• Pregnancy Outcomes in Women With Unexplained Recurrent Pregnancy Loss Treated With Low Dose Aspirin and Unfractionated Heparin
• Intralipid for Recurrent Miscarriage
• Effectiveness of Metformin in Recurrent Miscarriage in a Woman With Hyperinsulinaemia
• Pr-conceptional Progesterone for Unexplained Recurrent Miscarriage
• Preconceptional Thromboprophylaxis in Recurrent PREGNANCY LOSSES Caused by Antiphospholipid Syndrome
• Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent Miscarriages
• Optimum Misoprostol Dose Prior to Office Hysteroscopy
• Low Molecular Weight Heparin in Recurrent Miscarriage With Negative Antiphospholipid Antibodies
• Role of Sildenafil Citrate in Patients With Unexplained Recurrent Miscarriages
• Role of Hypersensitivity to Female Sex Hormones in Women With Unexplained Recurrent Pregnancy Loss
• Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome
• Low Molecular Weight Heparin and/or Aspirin in Prevention of Habitual Abortion
• Use of G-CSF for the Treatment of Unexplained Recurrent Miscarriage
• Trial of the Efficacy of Intravenous Immunoglobulin for Treating Women With Unexplained Secondary Recurrent Miscarriage
• Low Molecular Weight Heparin and Aspirin in the Treatment of Recurrent Pregnancy Loss: A RCT
• Effectiveness of Dalteparin Therapy as Intervention in Recurrent Pregnancy Loss
• Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent Miscarriage